Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Bioharvest Sciences Inc C.BHSC

Alternate Symbol(s):  CNVCF

Consumer Defensive Household & Personal Products Biotechnology Cannabis
BioHarvest Sciences Inc. is a Canada-based biotechnology company. The Company offers Botanical Synthesis, its patented technology process to grow plant-based molecules, without the need to grow the underlying plant. The Company is leveraging its Botanical Synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two major business... see more

Recent & Breaking News (CSE:BHSC)

BioHarvest Sciences Reports Q2 2023 Results Demonstrating Continued Growth Momentum

Newsfile August 30, 2023

BioHarvest Sciences to Host Virtual Shareholder Presentation September 6, 2023

Newsfile August 24, 2023

Canadian Securities Exchange Reports June 2023 Performance Figures

Newsfile July 20, 2023

BioHarvest Sciences Inc. Announces Closing of Private Placement of Convertible Notes

Newsfile July 18, 2023

BioHarvest Chief Medical Officer Shares Personal Journey at Collision Conference

Newsfile June 30, 2023

BioHarvest Sciences Chief Medical Officer to Speak at Collision Conference in Toronto

Newsfile June 27, 2023

BioHarvest Participates at Major Jefferies Investment Conference Tuesday June 27

Newsfile June 26, 2023

BioHarvest Unveils New Consumption Categories for its Flagship Product VINIA

Newsfile June 21, 2023

BioHarvest Sciences Adds Renowned Scientist to Scientific Advisory Board

Newsfile June 6, 2023

BioHarvest Reports Q1 2023 Results Demonstrating Strong Year Over Year Growth

Newsfile May 31, 2023

BioHarvest Adds over 25,000 US Customers in Last 365 Days and Congratulates NFL "Team VINIA" Prospects on Draft Day Success

Newsfile May 4, 2023

BioHarvest Sciences Named Honorable Mention in Wellness Category of Fast Company's 2023 World Changing Ideas Awards

Newsfile May 3, 2023

BioHarvest Sciences Contributing VINIA to NFL Training Camp Preparation

Newsfile April 27, 2023

BioHarvest Sciences to Host Virtual Shareholder Presentation May 4, 2pm ET

Newsfile April 26, 2023

BioHarvest Sciences Hires Dr. Ilana Belzer as Chief Operating Officer

Newsfile April 19, 2023

BioHarvest Sciences Announces Major Media Campaign to Focus on VINIA Real Stories

Newsfile April 4, 2023

BioHarvest Sciences (CSE:BHSC) announces $8M private placement

John Ballem  February 21, 2023

BioHarvest Sciences Announces a Private Placement of up to CAD $8M of Convertible Notes to Grow Core Business

Newsfile February 21, 2023

BioHarvest Sciences Collaborating with Yo Murphy and NFL Prospects to Build Awareness of Blood Flow Importance

Newsfile February 16, 2023

BioHarvest Sciences Announces Clinical Study in Patients with Multiple Sclerosis-Related Optic Neuritis

Newsfile February 14, 2023